Concerns about socioeconomic well-being were the main reason why people voted for a certain political party.
L’expertise universitaire, l’exigence journalistique
Articles sur COVID-19
Affichage de 2461 à 2480 de 7967 articles
Upwards of 60% of the world needs to be vaccinated to suppress COVID-19 – even with an extra billion doses, that target looks very far away.
We often underestimate dangerous risks because they are slow or we think we are in more control of them than we actually are.
The vaccine works by the same principles as the Pfizer and Moderna vaccines, and could be manufactured in Australia.
Values in adulthood rarely change. But major events, like wars — and pandemics — can shift our priorities.
The pandemic has made universities rethink the importance of helping students build social and mentoring connections to support student engagement and academic success.
New theories about the lab leak don’t make the case for it any stronger, but do reveal the messiness of how historical events play out.
Canadians are increasingly turning to private messaging apps where COVID-19 misinformation and conspiracy theories spread in an unregulated manner.
Natural disaster is a misnomer. Disasters occur due to societal failures, not nature.
A wider understanding of cultural values will be crucial to the successful implementation of contact-tracing technology across the world.
While the loss of contact learning time can be quantified, it’s more difficult to quantify the effect of school closures on learning outcomes.
Local companies in Africa would find it very challenging to be cost-competitive in the longer run when the current worldwide scarcity of COVID-19 vaccines is overcome.
The research community is taking a closer look at the lab-leak hypothesis for the origin of COVID-19, prompting discussion about the risks and benefits of engineering viruses.
Covax was doomed to failure from the start. It is already running into three major problems.
China has administered more than one billion doses of its homegrown COVID-19 vaccines, the majority of which were developed by local companies Sinovac and Sinopharm. So what do we know about them?
In Australia, a preference for a particular brand of COVID vaccine is likely to change, depending on the latest health advice, and media reports.
New entrepreneurs borne of the pandemic will need support to survive and thrive after the crisis. Here’s how business accelerators need to change in order to help them succeed post-pandemic.
Psychologists have identified three potential barriers to vaccination: capability, opportunity and motivation.
In Ethiopia’s new and unsettled political space, there are issues related to the current electoral rules, the performance and strength of the opposition parties, and to campaigning.
A new government with popular legitimacy will have power to address lingering political, economic and security challenges.
Les contributeurs les plus fréquents
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Senior Research Fellow in Global Health, University of Southampton
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Professor of Medicine, University of East Anglia
-
Associate Professor, School of Population Health, UNSW Sydney
-
Professor of Medicine, University of Virginia
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Public Health, University of Sheffield
